2018
DOI: 10.1136/tobaccocontrol-2018-054307
|View full text |Cite
|
Sign up to set email alerts
|

Basic economic gap related to smoking: reconciling tobacco tax receipts and economic costs of smoking-attributable diseases

Abstract: BackgroundTobacco tax rates set by various governments are not based on the idea that tax receipts should cover the costs incurred by smoking. It can be assumed that tobacco tax receipts (TTR) differ from the costs of smoking. The aim is to determine the global basic economic gap (BEG) between TTR and the economic costs of smoking-attributable diseases (ECS).MethodsBEG is described as the difference between the ECS and TTR. A total of 124 countries representing 94% of global tobacco consumption were included i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 21 publications
0
4
0
Order By: Relevance
“…Smoking has significant negative effects on human health, resulting in a large number of physical and mental illnesses and premature deaths (Doll et al, 2004;Johnson et al, 2003;Lasser et al, 2000;Smith et al, 2014;Thun et al, 2013;WHO, 2019) as well as high social costs including healthcare costs of smokers, second-hand smoking costs, employers' costs of smoking employees, cleaning up after smoking, damages incurred as a result of cigarette fires, and many others, borne by the whole society (David, 2018;David, 2019). Tobacco consumption is the most common preventable cause of premature death (Samet, 2013) and according to various estimates, smoking shortens life by an average of about 5 -15 years (CDC, 2008;John and Hanke, 2015;Streppel et al, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…Smoking has significant negative effects on human health, resulting in a large number of physical and mental illnesses and premature deaths (Doll et al, 2004;Johnson et al, 2003;Lasser et al, 2000;Smith et al, 2014;Thun et al, 2013;WHO, 2019) as well as high social costs including healthcare costs of smokers, second-hand smoking costs, employers' costs of smoking employees, cleaning up after smoking, damages incurred as a result of cigarette fires, and many others, borne by the whole society (David, 2018;David, 2019). Tobacco consumption is the most common preventable cause of premature death (Samet, 2013) and according to various estimates, smoking shortens life by an average of about 5 -15 years (CDC, 2008;John and Hanke, 2015;Streppel et al, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…An increase in the tobacco tax would lead to savings in the health sector (17). Another study deals with the global economic difference between tobacco tax receipts and the economic costs of smoking-attributable diseases (18). Tobacco tax increases deliver sizeable health gains and health sector cost savings (19).…”
Section: Introductionmentioning
confidence: 99%
“…There is indisputable evidence that tobacco use is a substantial public health concern with considerable economic ramifications [1][2][3][4] . The World Health Organization reports that global smoking-related diseases cost US$1911 billion per year and that by 2030 more than 8 million people will die annually from tobacco use 5,6 . The regions of the World do not share equally the burden of tobacco-related disease and death.…”
Section: Introductionmentioning
confidence: 99%
“…The regions of the World do not share equally the burden of tobacco-related disease and death. For instance, 40% of the costs of smoking are currently borne by developing nations and it is projected that by 2030 more than 80% of premature deaths due to tobacco will occur in lowand middle-income countries [5][6][7] . Among developing nations, tobacco use in African countries has received little attention given the perceived low rate of use and the critical need for more interventions for both infectious and non-infectious diseases.…”
Section: Introductionmentioning
confidence: 99%